Check out some of the companies making the biggest moves midday: MarineMax — Shares soared 46% after the boat and yacht retailer agreed to be sold to Blackstone Infrastructure’s Safe Harbor Marinas for $53 a share in cash, or $1.5 billion. The deal’s expected to close by the end of 2026. Varex Imaging — The imaging component maker’s stock climbed 48% after Teledyne Technologies agreed to buy Varex for $18.90 a share in cash. The deal is expected to close in early 2027. Teledyne rose a fraction. Artificial intelligence infrastructure — Stocks tied to artificial intelligence infrastructure slid. The Global X Data Center & Digital Infrastructure ETF (DTCR) lost 1%. Corning ‘s stock fell more than 3%. Photonics stocks Coherent and Lumentum dropped 12% and more than 6%, respectively. Doximity — Shares of the digital medical platform fell 5%. On Friday, the stock surged more than 32% after CEO Jeffrey Tangney said the company was seeing huge margins on its artificial intelligence search tool. NetApp — Shares gained 6% after Morgan Stanley lifted the data storage company to equal weight from underweight. “Improving storage fundamentals support higher earnings estimates, although valuation at peak P/E already reflects meaningful credit for this improving outlook,” wrote analyst Erik Woodring. Verisk Analytics — Shares tumbled more than 5% after a Delaware judge on Friday ruled the data analytics company must proceed with a $2.35 billion acquisition of AccuLynx. Verisk previously terminated a deal in December because a Federal Trade Commission review of the merger was not completed by the transaction’s termination date. Apple — The iPhone maker’s stock dipped 2% after Jefferies downgraded Apple to underperform from hold. According to the bank’s supply chain checks, analysts have concluded than an all-glass iPhone by Apple , something the company has never publicly announced, appears to be canceled. That puts pressure on Apple, which is trying to sell more expensive devices to combat the rising cost of memory. Everpure — The data storage provider’s stock surged 9% after Morgan Stanley and Susquehanna raised their investment recommendations. Berkshire Hathaway — Shares rose almost 2% after the Geico insurance owner said Saturday it saw operating earnings grow 16% in the second quarter. Manufacturing, service and retailing earnings saw strong growth, as did energy profits. Insurance was weaker, with investment income declining 9%. Intel — The stock fell nearly 3% after the chipmaker announced it will offer $15 billion in common stock . Intel plans to use the cash for general corporate purposes, which may include capital expenditures and working capital. Monday.com — The work management software provider’s shares dropped more than 6% after guidance disappointed Wall Street. Monday.com sees revenue in a range of $368 million to $370 million for the current quarter, while the FactSet consensus called for $372.8 million. Guidance for full-year revenue was roughly in line with expectations. Ebay — The online retailer’s stock dropped 3% after Bloomberg said GameStop is considering abandoning its takeover offer. GameStop’s unsolicited bid was originally rejected by eBay in May , when it was called “neither credible nor attractive.” Hewlett Packard Enterprise — Shares rose 4% after Morgan Stanley upgraded HPE to overweight from equal-weight. Analysts said HPE has an attractive risk/reward profile, and that the market is underappreciating the asymmetry between HPE’s earnings power and valuation. Archer Aviation — Shares surged almost 8% after the aerospace company agreed to acquire three Boeing subsidiaries. Boeing is also taking an undisclosed stake in Archer. Archer CEO Adam Goldstein said the acquisitions will help the company diversify revenues and expand. Boeing’s stock gained a fraction. AbCellera Biologics — Shares soared 43% after the biotech company reported strong Phase 2 clinical results for its medication to treat hot flashes caused by menopause. “Phase 2 results showed best-in-class reductions in both frequency and severity of moderate-to-severe vasomotor symptoms after a single dose,” AbCellera said. N-Able — Shares plunged more than 37% after the software maker gave disappointing current-quarter guidance. N-able sees third-quarter revenue of about $135 million, short of the FactSet consensus estimate of almost $142 million. Adjusted EBITDA of $41.0 million to $42.0 million also missed the $46.3 million consensus estimate. Sionna Therapeutics — The stock collapsed 92% after the biotech’s cystic fibrosis drug failed to meet key endpoints in a proof-of-concept trial. Sionna said it was disappointed with the results and that it would not advance the drug as an add-on to standard of care. — With additional reporting by Davis Giangiulio, Darla Mercado, Alex Harring and Sarah Min
